Helicobacter pylori membrane phospholipids and membrane-associated proteins (H. pylori membrane components)

Helicobacter pylori membrane phospholipids and membrane-associated proteins constitute the complex structural and functional interface between the bacterium and the human gastric environment. The membrane is unique for its inclusion of cholesteryl glucosides, which the bacterium extracts from the host to enhance acid resistance and evade immune detection (Hirai et al., 1995; PubMed). Membrane-associated proteins include critical adhesins like BabA and SabA, which facilitate persistent colonization by binding to gastric epithelial receptors, as well as transport systems and enzymes like urease that are essential for survival in the acidic stomach (Tshibangu-Kbamba & Yamaoka, 2021; PubMed). These components are the primary targets for triple and quadruple antibiotic therapies, where agents like bismuth salts directly disrupt the membrane and antibiotics like amoxicillin target membrane-bound synthesis proteins (NIH/StatPearls). Because this target represents a broad category of lipids and proteins rather than a single molecular entity, it is often used in the context of whole-cell vaccine development or the study of total membrane disruption by novel antimicrobial peptides (Kusters et al., 2006; Clinical Microbiology Reviews).

Other names

H. pylori cell envelopeHelicobacter pylori surface proteinsH. pylori outer membrane vesiclesH. pylori membrane-associated factors

Drugs targeting these components typically act by disrupting membrane integrity, inhibiting cell wall synthesis (via membrane-associated penicillin-binding proteins), blocking protein synthesis at the ribosome (indirectly affecting membrane protein turnover), or inhibiting the urease enzyme associated with the membrane to prevent acid neutralization (Kusters et al., 2006; NIH/StatPearls).